Advertise on podcast: Immunotherapy Talks with ACIR

Rating

★★★★★

from

2 reviews

Description

Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite size pieces to help you stay on top of the field. Stay tuned to hear which expert will be invited on our next episode!

Unlock Immunotherapy Talks with ACIR podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Immunotherapy Talks with ACIR podcast

#2 - A biomaterial-based vaccine

2022/06/02

In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells. GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab. Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/ Support the show

Teaser

2021/05/13

Introducing "Immunotherapy Talks". Reading research can be complicated — but it doesn’t have to be. In this podcast, ACIR digests the latest in cancer immunotherapy research into bite size pieces to help you stay on top the field. Support the show (https://donate2acir.raisely.com/)

#1- Hooked on immunotherapy

2021/05/14

In this first episode, our co-hosts talk about their background in immunology and what led them to it. GUEST: Ed Fritsch. PhD, presidential fellow at the Dana-Farber, co-author of "Molecular Cloning: A Laboratory Manual", and co-founder of ACIR. Support the show